Compounds > dioscin
Page last updated: 2024-09-03

dioscin and Endometrial Neoplasms

dioscin has been researched along with Endometrial Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cespedes-Acuña, CL; Li, XL; Ma, RH; Ni, ZJ; Thakur, K; Wei, ZJ; Zhang, JG; Zhang, XX1
Cespedes-Acuña, CL; Li, XL; Ma, RH; Ni, ZJ; Thakur, K; Wang, S; Wei, ZJ; Zhang, JG1

Other Studies

2 other study(ies) available for dioscin and Endometrial Neoplasms

ArticleYear
Integrated miRNA and mRNA omics reveal dioscin suppresses migration and invasion via MEK/ERK and JNK signaling pathways in human endometrial carcinoma in vivo and in vitro.
    Journal of ethnopharmacology, 2023, Mar-01, Volume: 303

    Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; Humans; MAP Kinase Signaling System; MicroRNAs; Mitogen-Activated Protein Kinase Kinases

2023
Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2021, Volume: 148

    Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Proliferation; Diosgenin; Down-Regulation; Drug Screening Assays, Antitumor; Endometrial Neoplasms; Female; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Mitochondria; Reactive Oxygen Species; Signal Transduction; Up-Regulation

2021